Fundraising Fox
Rarity Bioscience
Uppsala, SE · Founded 2021 · 28 employees on LinkedIn · 3 known investors
Find your way into Rarity Bioscience
Sign up to see every warm intro you have to Rarity Bioscience
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Rarity Bioscience team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Rarity Bioscience develops superRCA, a molecular detection technology that identifies DNA mutations with exceptional sensitivity for precision medicine applications. The company commercializes diagnostic assays and kits for clinical and research settings, with initial focus on leukemia and cancer detection.
Founders & leadership
Rarity Bioscience was founded in 2021 by Lei Chen, Ulf Landegren, and Per Matsson.
Investors · 3
How we know: Navigare Ventures's portfolio page · a partner's Signal profile · funding news · raritybioscience.com · Not right? Tell us
How we know: Novalis Biotech's portfolio page · funding news · raritybioscience.com · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountfunding roundJun 2024
Navigare Ventures (lead), Novalis Biotech, UU Invest
Source ↗ - Undisclosed amountseed roundNov 2022
Navigare Ventures, UU Invest
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Rarity Bioscience do?
- Rarity Bioscience develops superRCA, a molecular detection technology that identifies DNA mutations with exceptional sensitivity for precision medicine applications. The company commercializes diagnostic assays and kits for clinical and research settings, with initial focus on leukemia and cancer detection.
- Who founded Rarity Bioscience?
- Rarity Bioscience was founded by Lei Chen, Ulf Landegren, Per Matsson in 2021.
- Who are Rarity Bioscience's investors?
- Rarity Bioscience's investors include Navigare Ventures, Novalis Biotech.
- Where is Rarity Bioscience headquartered?
- Rarity Bioscience is headquartered in Uppsala, SE.